Steven Edmundowicz
Concepts (483)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cholangiopancreatography, Endoscopic Retrograde | 40 | 2026 | 223 | 4.010 |
Why?
| | Endoscopy, Gastrointestinal | 29 | 2023 | 237 | 3.470 |
Why?
| | Endosonography | 31 | 2025 | 162 | 2.030 |
Why?
| | Esophageal Neoplasms | 15 | 2026 | 351 | 1.950 |
Why?
| | Bariatric Surgery | 12 | 2019 | 258 | 1.690 |
Why?
| | Endoscopy, Digestive System | 16 | 2021 | 142 | 1.640 |
Why?
| | Pancreatitis | 15 | 2026 | 147 | 1.540 |
Why?
| | Pancreatic Neoplasms | 20 | 2023 | 947 | 1.510 |
Why?
| | Adenoma | 12 | 2023 | 219 | 1.400 |
Why?
| | Endoscopy | 13 | 2020 | 322 | 1.400 |
Why?
| | Barrett Esophagus | 12 | 2026 | 172 | 1.380 |
Why?
| | Gastric Balloon | 6 | 2018 | 17 | 1.280 |
Why?
| | Weight Loss | 11 | 2019 | 867 | 1.250 |
Why?
| | Obesity | 17 | 2019 | 3149 | 1.220 |
Why?
| | Gastroplasty | 5 | 2019 | 32 | 1.200 |
Why?
| | Stents | 20 | 2025 | 570 | 1.200 |
Why?
| | Adenocarcinoma | 14 | 2026 | 928 | 1.190 |
Why?
| | Endoscopic Ultrasound-Guided Fine Needle Aspiration | 10 | 2025 | 62 | 1.180 |
Why?
| | Gastrointestinal Hemorrhage | 4 | 2019 | 139 | 1.060 |
Why?
| | Pancreatic Ducts | 11 | 2024 | 82 | 0.970 |
Why?
| | Colonic Neoplasms | 6 | 2015 | 258 | 0.970 |
Why?
| | Stomach Neoplasms | 5 | 2020 | 128 | 0.940 |
Why?
| | Drainage | 12 | 2024 | 189 | 0.930 |
Why?
| | Gastroenterology | 10 | 2019 | 191 | 0.880 |
Why?
| | Colonic Polyps | 7 | 2015 | 88 | 0.880 |
Why?
| | Colonoscopy | 12 | 2023 | 266 | 0.860 |
Why?
| | Gastroesophageal Reflux | 11 | 2020 | 237 | 0.830 |
Why?
| | Bile Duct Neoplasms | 4 | 2020 | 133 | 0.740 |
Why?
| | Cholestasis | 3 | 2020 | 217 | 0.690 |
Why?
| | Gastrointestinal Diseases | 4 | 2022 | 222 | 0.670 |
Why?
| | Duodenoscopes | 2 | 2020 | 7 | 0.650 |
Why?
| | Neoplasm Recurrence, Local | 7 | 2026 | 1166 | 0.640 |
Why?
| | Duodenum | 4 | 2019 | 80 | 0.640 |
Why?
| | Pancreatitis, Chronic | 5 | 2024 | 65 | 0.630 |
Why?
| | Middle Aged | 97 | 2026 | 36821 | 0.620 |
Why?
| | Esophagus | 8 | 2019 | 262 | 0.620 |
Why?
| | Humans | 165 | 2026 | 147293 | 0.610 |
Why?
| | Pancreatic Pseudocyst | 5 | 2024 | 18 | 0.610 |
Why?
| | Pancreatic Diseases | 6 | 2023 | 66 | 0.600 |
Why?
| | Biliary Tract Neoplasms | 1 | 2019 | 31 | 0.590 |
Why?
| | Esophagoscopy | 9 | 2026 | 223 | 0.590 |
Why?
| | Obesity, Morbid | 7 | 2019 | 298 | 0.590 |
Why?
| | Biopsy, Fine-Needle | 8 | 2017 | 79 | 0.590 |
Why?
| | Aged | 76 | 2026 | 26514 | 0.580 |
Why?
| | Indomethacin | 4 | 2025 | 77 | 0.580 |
Why?
| | Catheterization | 9 | 2024 | 184 | 0.570 |
Why?
| | Clinical Competence | 11 | 2020 | 1260 | 0.530 |
Why?
| | Prospective Studies | 38 | 2026 | 8164 | 0.530 |
Why?
| | Learning Curve | 6 | 2019 | 71 | 0.520 |
Why?
| | Cross Infection | 1 | 2020 | 261 | 0.510 |
Why?
| | Radiation Exposure | 1 | 2017 | 63 | 0.500 |
Why?
| | Endoscopic Mucosal Resection | 5 | 2022 | 39 | 0.500 |
Why?
| | Intestine, Small | 2 | 2020 | 168 | 0.500 |
Why?
| | Gastrostomy | 5 | 2019 | 130 | 0.490 |
Why?
| | Treatment Outcome | 38 | 2026 | 11947 | 0.490 |
Why?
| | Colonic Diseases | 3 | 2013 | 37 | 0.490 |
Why?
| | Radiation Injuries | 1 | 2017 | 149 | 0.480 |
Why?
| | Jejunum | 2 | 2015 | 37 | 0.480 |
Why?
| | Male | 98 | 2026 | 73950 | 0.460 |
Why?
| | Self Expandable Metallic Stents | 3 | 2022 | 17 | 0.450 |
Why?
| | Smell | 1 | 2016 | 130 | 0.450 |
Why?
| | Pathology, Clinical | 1 | 2015 | 29 | 0.450 |
Why?
| | Female | 100 | 2026 | 80076 | 0.440 |
Why?
| | Gastrointestinal Neoplasms | 2 | 2013 | 74 | 0.440 |
Why?
| | Cholelithiasis | 8 | 2010 | 36 | 0.440 |
Why?
| | Pancreas | 7 | 2021 | 345 | 0.430 |
Why?
| | Lithotripsy | 6 | 2024 | 49 | 0.430 |
Why?
| | Laparoscopy | 6 | 2020 | 486 | 0.420 |
Why?
| | Suction | 2 | 2017 | 32 | 0.420 |
Why?
| | Catheter Ablation | 5 | 2022 | 360 | 0.400 |
Why?
| | Postoperative Hemorrhage | 3 | 2017 | 106 | 0.400 |
Why?
| | Anti-Inflammatory Agents, Non-Steroidal | 5 | 2026 | 347 | 0.390 |
Why?
| | Gallstones | 6 | 1996 | 35 | 0.390 |
Why?
| | Adult | 62 | 2026 | 41405 | 0.370 |
Why?
| | Postoperative Complications | 11 | 2024 | 3022 | 0.360 |
Why?
| | Body Weight | 1 | 2016 | 976 | 0.360 |
Why?
| | Sensitivity and Specificity | 11 | 2019 | 2017 | 0.360 |
Why?
| | Propofol | 4 | 2023 | 88 | 0.350 |
Why?
| | Diabetes Mellitus, Type 2 | 2 | 2017 | 2627 | 0.340 |
Why?
| | Biopsy | 5 | 2019 | 1093 | 0.340 |
Why?
| | Aged, 80 and over | 24 | 2025 | 8430 | 0.340 |
Why?
| | Gastroscopy | 4 | 2014 | 18 | 0.340 |
Why?
| | Precancerous Conditions | 4 | 2017 | 166 | 0.340 |
Why?
| | Quality Indicators, Health Care | 5 | 2018 | 337 | 0.320 |
Why?
| | Bile Ducts | 5 | 2014 | 68 | 0.320 |
Why?
| | Colorectal Neoplasms | 5 | 2022 | 876 | 0.320 |
Why?
| | Pancreatic Cyst | 3 | 2018 | 50 | 0.310 |
Why?
| | Duodenal Neoplasms | 2 | 2023 | 26 | 0.310 |
Why?
| | Cytodiagnosis | 2 | 2020 | 31 | 0.310 |
Why?
| | Ampulla of Vater | 3 | 2023 | 40 | 0.310 |
Why?
| | Pancreatitis, Acute Necrotizing | 3 | 2023 | 14 | 0.300 |
Why?
| | Insufflation | 1 | 2009 | 14 | 0.300 |
Why?
| | Constriction, Pathologic | 6 | 2022 | 252 | 0.290 |
Why?
| | In Situ Hybridization, Fluorescence | 2 | 2020 | 330 | 0.280 |
Why?
| | Common Bile Duct Neoplasms | 2 | 2023 | 28 | 0.280 |
Why?
| | Esophagogastric Junction | 3 | 2019 | 55 | 0.280 |
Why?
| | Retrospective Studies | 36 | 2025 | 17560 | 0.280 |
Why?
| | Cholecystectomy, Laparoscopic | 6 | 2008 | 56 | 0.270 |
Why?
| | Calculi | 3 | 2019 | 16 | 0.260 |
Why?
| | Carbon Dioxide | 1 | 2009 | 228 | 0.260 |
Why?
| | Follow-Up Studies | 17 | 2026 | 5476 | 0.250 |
Why?
| | Decompression, Surgical | 2 | 2023 | 117 | 0.250 |
Why?
| | Prosthesis Implantation | 3 | 2019 | 156 | 0.250 |
Why?
| | Gastrointestinal Stromal Tumors | 3 | 2015 | 41 | 0.240 |
Why?
| | Sphincterotomy, Endoscopic | 6 | 2019 | 29 | 0.240 |
Why?
| | Endoscopes, Gastrointestinal | 1 | 2006 | 13 | 0.230 |
Why?
| | Quality of Life | 11 | 2024 | 3246 | 0.230 |
Why?
| | Thoracoscopy | 1 | 2006 | 60 | 0.230 |
Why?
| | Body Mass Index | 7 | 2019 | 2470 | 0.230 |
Why?
| | Pancreatectomy | 2 | 2021 | 290 | 0.220 |
Why?
| | Fluid Therapy | 1 | 2026 | 156 | 0.220 |
Why?
| | Neuroendocrine Tumors | 2 | 2018 | 123 | 0.220 |
Why?
| | Mental Recall | 1 | 2006 | 225 | 0.210 |
Why?
| | Esophageal Sphincter, Lower | 2 | 2015 | 14 | 0.210 |
Why?
| | Polyvinyls | 1 | 2004 | 19 | 0.210 |
Why?
| | Magnets | 2 | 2015 | 21 | 0.210 |
Why?
| | Abdominal Pain | 4 | 2026 | 149 | 0.210 |
Why?
| | Plastics | 3 | 2022 | 50 | 0.200 |
Why?
| | Societies, Medical | 3 | 2018 | 914 | 0.200 |
Why?
| | Early Detection of Cancer | 5 | 2022 | 506 | 0.200 |
Why?
| | Lymphoma | 1 | 2025 | 253 | 0.200 |
Why?
| | Double-Blind Method | 8 | 2026 | 2080 | 0.200 |
Why?
| | Administration, Rectal | 4 | 2026 | 14 | 0.200 |
Why?
| | Periodicals as Topic | 1 | 2006 | 211 | 0.200 |
Why?
| | Gastric Bypass | 2 | 2017 | 126 | 0.190 |
Why?
| | Lymphoma, Large B-Cell, Diffuse | 1 | 2025 | 196 | 0.190 |
Why?
| | Ablation Techniques | 3 | 2017 | 36 | 0.190 |
Why?
| | Common Bile Duct | 3 | 2009 | 14 | 0.190 |
Why?
| | Recurrence | 6 | 2026 | 1151 | 0.180 |
Why?
| | Gastrointestinal Tract | 1 | 2025 | 204 | 0.180 |
Why?
| | Fluoroscopy | 3 | 2019 | 180 | 0.180 |
Why?
| | Internet | 2 | 2009 | 696 | 0.180 |
Why?
| | Patient Satisfaction | 1 | 2006 | 718 | 0.180 |
Why?
| | Prostheses and Implants | 3 | 2013 | 137 | 0.180 |
Why?
| | Pneumonia, Aspiration | 2 | 2019 | 16 | 0.170 |
Why?
| | Incidence | 8 | 2026 | 2954 | 0.170 |
Why?
| | Carcinoma, Pancreatic Ductal | 3 | 2017 | 299 | 0.170 |
Why?
| | Carcinoembryonic Antigen | 3 | 2018 | 40 | 0.160 |
Why?
| | Deglutition Disorders | 3 | 2019 | 159 | 0.160 |
Why?
| | Intestinal Perforation | 2 | 2018 | 46 | 0.160 |
Why?
| | Risk Factors | 14 | 2025 | 11017 | 0.160 |
Why?
| | Varicose Veins | 1 | 2020 | 16 | 0.160 |
Why?
| | Logistic Models | 7 | 2024 | 2142 | 0.160 |
Why?
| | Prosthesis Design | 3 | 2019 | 363 | 0.160 |
Why?
| | Esophageal and Gastric Varices | 1 | 2020 | 36 | 0.160 |
Why?
| | Biliary Tract Diseases | 4 | 2014 | 33 | 0.150 |
Why?
| | Machine Learning | 1 | 2026 | 596 | 0.150 |
Why?
| | Anesthesia | 1 | 2023 | 257 | 0.150 |
Why?
| | Equipment Design | 6 | 2020 | 527 | 0.150 |
Why?
| | Deep Sedation | 2 | 2010 | 16 | 0.150 |
Why?
| | Cell-Free System | 1 | 2019 | 54 | 0.150 |
Why?
| | Neoplasm Staging | 5 | 2017 | 1492 | 0.150 |
Why?
| | Fiducial Markers | 1 | 2019 | 9 | 0.150 |
Why?
| | Urinary Calculi | 1 | 2019 | 10 | 0.150 |
Why?
| | Radiotherapy, Image-Guided | 1 | 2019 | 40 | 0.140 |
Why?
| | Needles | 1 | 2019 | 63 | 0.140 |
Why?
| | Watchful Waiting | 3 | 2019 | 90 | 0.140 |
Why?
| | Infection Control | 1 | 2020 | 174 | 0.140 |
Why?
| | Esophageal Stenosis | 1 | 2019 | 60 | 0.140 |
Why?
| | Academic Medical Centers | 3 | 2023 | 566 | 0.140 |
Why?
| | Metals | 4 | 2023 | 138 | 0.140 |
Why?
| | Abdomen | 2 | 2016 | 142 | 0.130 |
Why?
| | Cystadenoma, Serous | 1 | 2018 | 18 | 0.130 |
Why?
| | Time Factors | 10 | 2026 | 7173 | 0.130 |
Why?
| | Aneurysm, False | 1 | 2018 | 46 | 0.130 |
Why?
| | Reproducibility of Results | 7 | 2020 | 3448 | 0.130 |
Why?
| | Cystadenoma, Mucinous | 2 | 2015 | 11 | 0.130 |
Why?
| | Cystadenocarcinoma, Mucinous | 2 | 2015 | 12 | 0.130 |
Why?
| | Obesity Management | 1 | 2017 | 12 | 0.130 |
Why?
| | Delayed Diagnosis | 1 | 2018 | 101 | 0.130 |
Why?
| | Calcinosis | 1 | 2019 | 234 | 0.130 |
Why?
| | Suture Techniques | 3 | 2017 | 138 | 0.130 |
Why?
| | Pancreaticoduodenectomy | 2 | 2016 | 149 | 0.130 |
Why?
| | Liver Neoplasms | 1 | 2023 | 787 | 0.120 |
Why?
| | Diagnostic Tests, Routine | 1 | 2018 | 107 | 0.120 |
Why?
| | Simulation Training | 1 | 2019 | 136 | 0.120 |
Why?
| | Insurance, Health, Reimbursement | 1 | 2017 | 98 | 0.120 |
Why?
| | Diet Therapy | 1 | 2016 | 36 | 0.120 |
Why?
| | Metaplasia | 4 | 2022 | 57 | 0.120 |
Why?
| | Immunoassay | 1 | 2017 | 109 | 0.120 |
Why?
| | Polymerase Chain Reaction | 1 | 2019 | 1046 | 0.120 |
Why?
| | Education, Medical, Graduate | 2 | 2019 | 568 | 0.120 |
Why?
| | Stomach | 1 | 2016 | 111 | 0.120 |
Why?
| | Risk Assessment | 9 | 2026 | 3784 | 0.120 |
Why?
| | Respiratory Insufficiency | 2 | 2010 | 330 | 0.120 |
Why?
| | Population Surveillance | 2 | 2017 | 486 | 0.120 |
Why?
| | Neoplasms, Cystic, Mucinous, and Serous | 1 | 2016 | 27 | 0.110 |
Why?
| | Bariatric Medicine | 1 | 2015 | 2 | 0.110 |
Why?
| | Single-Blind Method | 5 | 2019 | 319 | 0.110 |
Why?
| | Young Adult | 11 | 2025 | 14437 | 0.110 |
Why?
| | Intubation, Gastrointestinal | 1 | 1996 | 81 | 0.110 |
Why?
| | Colon, Ascending | 1 | 2015 | 3 | 0.110 |
Why?
| | Dissection | 1 | 2015 | 58 | 0.110 |
Why?
| | Neoplasms, Multiple Primary | 1 | 2015 | 58 | 0.110 |
Why?
| | Documentation | 1 | 2017 | 204 | 0.110 |
Why?
| | Life Style | 2 | 2018 | 504 | 0.110 |
Why?
| | Dogs | 1 | 2016 | 518 | 0.110 |
Why?
| | Intestinal Mucosa | 3 | 2017 | 676 | 0.110 |
Why?
| | Fellowships and Scholarships | 1 | 2019 | 357 | 0.110 |
Why?
| | Cholecystectomy | 4 | 2009 | 61 | 0.110 |
Why?
| | Referral and Consultation | 3 | 2019 | 886 | 0.110 |
Why?
| | Proton Pump Inhibitors | 3 | 2020 | 109 | 0.110 |
Why?
| | Aptitude | 1 | 2014 | 30 | 0.110 |
Why?
| | Peristalsis | 2 | 1991 | 30 | 0.110 |
Why?
| | Pilot Projects | 2 | 2013 | 1912 | 0.110 |
Why?
| | Leiomyoma | 1 | 2015 | 62 | 0.100 |
Why?
| | Colorectal Surgery | 1 | 2014 | 31 | 0.100 |
Why?
| | Hospitalization | 1 | 2025 | 2496 | 0.100 |
Why?
| | Multivariate Analysis | 4 | 2021 | 1550 | 0.100 |
Why?
| | Ulcer | 1 | 2014 | 37 | 0.100 |
Why?
| | Colectomy | 1 | 2014 | 107 | 0.100 |
Why?
| | Liver Cirrhosis | 2 | 2020 | 289 | 0.100 |
Why?
| | Biomarkers, Tumor | 3 | 2017 | 1339 | 0.100 |
Why?
| | Predictive Value of Tests | 6 | 2016 | 2133 | 0.100 |
Why?
| | Anastomosis, Roux-en-Y | 1 | 2013 | 26 | 0.100 |
Why?
| | Cholangiopancreatography, Magnetic Resonance | 1 | 2013 | 24 | 0.100 |
Why?
| | Patient Safety | 1 | 2016 | 356 | 0.090 |
Why?
| | Multidetector Computed Tomography | 1 | 2013 | 40 | 0.090 |
Why?
| | Community Health Services | 1 | 2014 | 231 | 0.090 |
Why?
| | Bile Duct Diseases | 1 | 2012 | 13 | 0.090 |
Why?
| | United States | 11 | 2026 | 16313 | 0.090 |
Why?
| | Hemorrhage | 1 | 2018 | 832 | 0.090 |
Why?
| | Ultrasonography, Interventional | 2 | 2015 | 166 | 0.090 |
Why?
| | Contrast Media | 1 | 1995 | 500 | 0.090 |
Why?
| | Cholecystitis | 1 | 1992 | 24 | 0.090 |
Why?
| | Health Care Costs | 1 | 2015 | 428 | 0.090 |
Why?
| | Cholestasis, Extrahepatic | 1 | 1991 | 3 | 0.090 |
Why?
| | Duodenal Diseases | 1 | 1991 | 8 | 0.090 |
Why?
| | Lymph Nodes | 2 | 2012 | 514 | 0.090 |
Why?
| | Diverticulum | 1 | 1991 | 15 | 0.090 |
Why?
| | Digestive System Diseases | 1 | 2011 | 28 | 0.090 |
Why?
| | Diagnosis, Differential | 6 | 2015 | 1518 | 0.090 |
Why?
| | Exercise Therapy | 1 | 2016 | 489 | 0.090 |
Why?
| | Esophageal Diseases | 1 | 1991 | 30 | 0.080 |
Why?
| | Sensation | 1 | 1991 | 55 | 0.080 |
Why?
| | Chest Pain | 1 | 1991 | 100 | 0.080 |
Why?
| | Deglutition | 1 | 1991 | 73 | 0.080 |
Why?
| | Hypotension | 1 | 2011 | 127 | 0.080 |
Why?
| | Patient Compliance | 1 | 2015 | 591 | 0.080 |
Why?
| | Severity of Illness Index | 1 | 2019 | 2973 | 0.080 |
Why?
| | Hepatic Duct, Common | 1 | 2010 | 5 | 0.080 |
Why?
| | Muscle, Smooth | 1 | 1991 | 153 | 0.080 |
Why?
| | Image Enhancement | 1 | 2011 | 201 | 0.080 |
Why?
| | Colonoscopes | 1 | 2009 | 5 | 0.080 |
Why?
| | Bile | 1 | 2009 | 26 | 0.080 |
Why?
| | Proteomics | 1 | 2017 | 1203 | 0.080 |
Why?
| | Cholecystostomy | 1 | 1989 | 4 | 0.080 |
Why?
| | Practice Guidelines as Topic | 1 | 2018 | 1598 | 0.080 |
Why?
| | Odds Ratio | 4 | 2016 | 1084 | 0.070 |
Why?
| | Disease Progression | 5 | 2017 | 2890 | 0.070 |
Why?
| | Length of Stay | 5 | 2025 | 1371 | 0.070 |
Why?
| | Hydrogel, Polyethylene Glycol Dimethacrylate | 1 | 2010 | 80 | 0.070 |
Why?
| | Sleep Apnea Syndromes | 1 | 2010 | 98 | 0.070 |
Why?
| | Loss of Heterozygosity | 1 | 2009 | 52 | 0.070 |
Why?
| | Abdominal Neoplasms | 1 | 2009 | 48 | 0.070 |
Why?
| | Equipment Safety | 2 | 2009 | 38 | 0.070 |
Why?
| | Tumor Burden | 3 | 2015 | 327 | 0.070 |
Why?
| | Intestinal Obstruction | 1 | 2009 | 55 | 0.070 |
Why?
| | DNA, Neoplasm | 1 | 2009 | 163 | 0.070 |
Why?
| | Cholangiography | 1 | 2008 | 10 | 0.070 |
Why?
| | Mutation | 1 | 2019 | 4130 | 0.070 |
Why?
| | Anesthetics | 1 | 2009 | 100 | 0.070 |
Why?
| | Choledocholithiasis | 1 | 2008 | 20 | 0.070 |
Why?
| | Quality Assurance, Health Care | 1 | 2010 | 343 | 0.070 |
Why?
| | Adolescent | 8 | 2025 | 22825 | 0.070 |
Why?
| | Ultrasonography | 4 | 1996 | 795 | 0.060 |
Why?
| | Health Services Research | 1 | 2010 | 392 | 0.060 |
Why?
| | Video Recording | 3 | 2014 | 222 | 0.060 |
Why?
| | Feeding Behavior | 1 | 2013 | 693 | 0.060 |
Why?
| | Biopsy, Needle | 2 | 2004 | 186 | 0.060 |
Why?
| | Positron-Emission Tomography | 1 | 2008 | 344 | 0.060 |
Why?
| | Acute Disease | 4 | 2008 | 1049 | 0.060 |
Why?
| | Republic of Korea | 1 | 2026 | 43 | 0.060 |
Why?
| | Hyperplasia | 2 | 2019 | 177 | 0.060 |
Why?
| | Pleural Diseases | 1 | 2006 | 23 | 0.060 |
Why?
| | Lymphoma, B-Cell, Marginal Zone | 1 | 2025 | 19 | 0.060 |
Why?
| | Research Design | 2 | 2016 | 1157 | 0.060 |
Why?
| | Pancreatic Fistula | 1 | 2006 | 35 | 0.060 |
Why?
| | Registries | 1 | 2015 | 2434 | 0.060 |
Why?
| | Lymphoma, Follicular | 1 | 2025 | 57 | 0.060 |
Why?
| | Prognosis | 5 | 2017 | 4383 | 0.060 |
Why?
| | Delphi Technique | 2 | 2017 | 347 | 0.060 |
Why?
| | Pain | 2 | 2022 | 794 | 0.060 |
Why?
| | Autonomic Nerve Block | 1 | 2024 | 10 | 0.050 |
Why?
| | Celiac Plexus | 1 | 2024 | 7 | 0.050 |
Why?
| | Health Care Surveys | 3 | 2014 | 538 | 0.050 |
Why?
| | Hospital Units | 1 | 2004 | 32 | 0.050 |
Why?
| | Ambulatory Surgical Procedures | 1 | 2025 | 79 | 0.050 |
Why?
| | Cohort Studies | 5 | 2020 | 6099 | 0.050 |
Why?
| | Cyst Fluid | 2 | 2018 | 20 | 0.050 |
Why?
| | Lymphoma, B-Cell | 1 | 2025 | 151 | 0.050 |
Why?
| | Hypoxia | 1 | 2011 | 1208 | 0.050 |
Why?
| | Tertiary Care Centers | 2 | 2016 | 196 | 0.050 |
Why?
| | Surveys and Questionnaires | 4 | 2015 | 6164 | 0.050 |
Why?
| | Diphenhydramine | 1 | 2023 | 36 | 0.050 |
Why?
| | Carcinoma, Squamous Cell | 1 | 2008 | 648 | 0.050 |
Why?
| | Midazolam | 1 | 2023 | 73 | 0.050 |
Why?
| | Efficiency, Organizational | 1 | 2004 | 141 | 0.050 |
Why?
| | Missouri | 2 | 2014 | 67 | 0.050 |
Why?
| | Observer Variation | 2 | 2014 | 358 | 0.050 |
Why?
| | Disposable Equipment | 2 | 2009 | 24 | 0.050 |
Why?
| | Electrocoagulation | 1 | 2023 | 35 | 0.050 |
Why?
| | Fentanyl | 1 | 2023 | 128 | 0.050 |
Why?
| | Proportional Hazards Models | 1 | 2026 | 1344 | 0.040 |
Why?
| | Necrosis | 1 | 2023 | 245 | 0.040 |
Why?
| | Pain Measurement | 1 | 2024 | 569 | 0.040 |
Why?
| | Esophagitis, Peptic | 1 | 2002 | 16 | 0.040 |
Why?
| | Animals | 3 | 2020 | 38410 | 0.040 |
Why?
| | Guidelines as Topic | 2 | 2015 | 268 | 0.040 |
Why?
| | Cholestasis, Intrahepatic | 1 | 2001 | 29 | 0.040 |
Why?
| | Endoscopes | 2 | 1998 | 17 | 0.040 |
Why?
| | Mass Screening | 1 | 2010 | 1375 | 0.040 |
Why?
| | Hypnotics and Sedatives | 1 | 2023 | 226 | 0.040 |
Why?
| | Bile Ducts, Intrahepatic | 1 | 2001 | 63 | 0.040 |
Why?
| | Neoplasms | 1 | 2016 | 2946 | 0.040 |
Why?
| | Tomography, X-Ray Computed | 3 | 2006 | 2791 | 0.040 |
Why?
| | Hyperthermia, Induced | 1 | 2002 | 120 | 0.040 |
Why?
| | Lumbar Vertebrae | 1 | 2023 | 259 | 0.040 |
Why?
| | Silicones | 1 | 2020 | 31 | 0.040 |
Why?
| | Portasystemic Shunt, Transjugular Intrahepatic | 1 | 2000 | 38 | 0.040 |
Why?
| | Hemostatic Techniques | 1 | 2000 | 52 | 0.040 |
Why?
| | Combined Modality Therapy | 2 | 2016 | 1281 | 0.040 |
Why?
| | Los Angeles | 1 | 2020 | 73 | 0.040 |
Why?
| | Fundoplication | 1 | 2020 | 52 | 0.040 |
Why?
| | Contraindications | 2 | 2017 | 90 | 0.040 |
Why?
| | Technology Assessment, Biomedical | 5 | 1998 | 45 | 0.040 |
Why?
| | Microscopy, Confocal | 1 | 2020 | 322 | 0.040 |
Why?
| | Equivalence Trials as Topic | 1 | 2019 | 35 | 0.040 |
Why?
| | Feasibility Studies | 2 | 2018 | 1147 | 0.040 |
Why?
| | Clinical Trials as Topic | 2 | 2015 | 1072 | 0.030 |
Why?
| | Adenocarcinoma, Mucinous | 2 | 2009 | 77 | 0.030 |
Why?
| | Probability | 2 | 2009 | 309 | 0.030 |
Why?
| | Electrosurgery | 1 | 1998 | 42 | 0.030 |
Why?
| | Electrodes | 1 | 1998 | 111 | 0.030 |
Why?
| | Radiology | 1 | 2000 | 176 | 0.030 |
Why?
| | Reference Standards | 1 | 2018 | 177 | 0.030 |
Why?
| | Swine | 1 | 2020 | 828 | 0.030 |
Why?
| | Surgical Instruments | 1 | 2018 | 51 | 0.030 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 2006 | 1431 | 0.030 |
Why?
| | General Surgery | 1 | 2000 | 207 | 0.030 |
Why?
| | Systemic Inflammatory Response Syndrome | 1 | 2018 | 96 | 0.030 |
Why?
| | Resuscitation | 1 | 2000 | 318 | 0.030 |
Why?
| | Statistics, Nonparametric | 2 | 2008 | 430 | 0.030 |
Why?
| | Practice Patterns, Physicians' | 3 | 2014 | 1379 | 0.030 |
Why?
| | Granulation Tissue | 1 | 2016 | 6 | 0.030 |
Why?
| | Manometry | 2 | 2001 | 98 | 0.030 |
Why?
| | Organizational Policy | 1 | 2017 | 78 | 0.030 |
Why?
| | Minimally Invasive Surgical Procedures | 2 | 2008 | 192 | 0.030 |
Why?
| | Neoplasm Seeding | 1 | 1996 | 7 | 0.030 |
Why?
| | Cystic Duct | 1 | 1996 | 4 | 0.030 |
Why?
| | Surgery, Computer-Assisted | 1 | 2017 | 86 | 0.030 |
Why?
| | Gastric Fistula | 1 | 1996 | 9 | 0.030 |
Why?
| | Tissue Banks | 1 | 2016 | 17 | 0.030 |
Why?
| | Fasciitis, Necrotizing | 1 | 1996 | 16 | 0.030 |
Why?
| | Cutaneous Fistula | 1 | 1996 | 17 | 0.030 |
Why?
| | Intestinal Fistula | 1 | 1996 | 18 | 0.030 |
Why?
| | Patient Admission | 1 | 2018 | 220 | 0.030 |
Why?
| | Foreign-Body Migration | 1 | 1996 | 33 | 0.030 |
Why?
| | Digestive System | 1 | 1995 | 29 | 0.030 |
Why?
| | Iopamidol | 1 | 1995 | 12 | 0.030 |
Why?
| | Diatrizoate Meglumine | 1 | 1995 | 6 | 0.030 |
Why?
| | Analgesics, Opioid | 1 | 2024 | 1167 | 0.030 |
Why?
| | Decision Trees | 1 | 2015 | 78 | 0.030 |
Why?
| | Prevalence | 2 | 2015 | 2889 | 0.030 |
Why?
| | Image-Guided Biopsy | 1 | 2015 | 41 | 0.030 |
Why?
| | Peritonitis | 1 | 1996 | 83 | 0.030 |
Why?
| | Survival Rate | 1 | 2000 | 2110 | 0.030 |
Why?
| | Quality-Adjusted Life Years | 1 | 2015 | 126 | 0.030 |
Why?
| | Osmolar Concentration | 1 | 1995 | 168 | 0.030 |
Why?
| | Markov Chains | 1 | 2015 | 132 | 0.030 |
Why?
| | Netherlands | 1 | 2015 | 85 | 0.030 |
Why?
| | Longitudinal Studies | 2 | 2015 | 3027 | 0.030 |
Why?
| | Weight Reduction Programs | 1 | 2017 | 141 | 0.030 |
Why?
| | Consensus | 1 | 2017 | 476 | 0.030 |
Why?
| | Costs and Cost Analysis | 1 | 2015 | 221 | 0.030 |
Why?
| | Child, Preschool | 2 | 2022 | 12016 | 0.030 |
Why?
| | Behavior Therapy | 1 | 2017 | 297 | 0.030 |
Why?
| | Incidental Findings | 1 | 2015 | 82 | 0.030 |
Why?
| | Patient Care Team | 1 | 2000 | 712 | 0.030 |
Why?
| | Clinical Protocols | 1 | 2016 | 284 | 0.030 |
Why?
| | Confidence Intervals | 1 | 2015 | 330 | 0.030 |
Why?
| | Patient Reported Outcome Measures | 1 | 2019 | 506 | 0.030 |
Why?
| | Outpatient Clinics, Hospital | 1 | 2014 | 80 | 0.030 |
Why?
| | Magnetic Resonance Imaging | 1 | 2006 | 3980 | 0.020 |
Why?
| | Electronic Health Records | 1 | 2022 | 1214 | 0.020 |
Why?
| | Advisory Committees | 1 | 2015 | 233 | 0.020 |
Why?
| | Monitoring, Physiologic | 1 | 1995 | 290 | 0.020 |
Why?
| | Health Status Indicators | 1 | 2014 | 168 | 0.020 |
Why?
| | Enteral Nutrition | 1 | 1995 | 218 | 0.020 |
Why?
| | Patient Participation | 1 | 2017 | 449 | 0.020 |
Why?
| | Medicaid | 1 | 2017 | 475 | 0.020 |
Why?
| | ROC Curve | 1 | 2015 | 626 | 0.020 |
Why?
| | Lipids | 1 | 2018 | 723 | 0.020 |
Why?
| | Socioeconomic Factors | 1 | 2017 | 1342 | 0.020 |
Why?
| | Evidence-Based Medicine | 1 | 2017 | 742 | 0.020 |
Why?
| | Program Evaluation | 1 | 2017 | 952 | 0.020 |
Why?
| | Sphincter of Oddi | 1 | 2012 | 5 | 0.020 |
Why?
| | Cost-Benefit Analysis | 1 | 2015 | 653 | 0.020 |
Why?
| | Radio Waves | 2 | 2003 | 28 | 0.020 |
Why?
| | Colic | 1 | 1992 | 10 | 0.020 |
Why?
| | Mediastinum | 1 | 2012 | 23 | 0.020 |
Why?
| | Esophagitis | 1 | 2013 | 68 | 0.020 |
Why?
| | Patient Selection | 1 | 2017 | 746 | 0.020 |
Why?
| | Adenoma, Villous | 1 | 2012 | 2 | 0.020 |
Why?
| | Mucous Membrane | 1 | 2013 | 130 | 0.020 |
Why?
| | Intensive Care Units | 1 | 2018 | 928 | 0.020 |
Why?
| | Blood Pressure | 1 | 2018 | 1785 | 0.020 |
Why?
| | Injections, Intravenous | 1 | 2011 | 198 | 0.020 |
Why?
| | Anesthetics, Intravenous | 1 | 2011 | 69 | 0.020 |
Why?
| | Medicare | 1 | 2017 | 915 | 0.020 |
Why?
| | Heartburn | 2 | 2001 | 12 | 0.020 |
Why?
| | Decision Support Techniques | 1 | 2015 | 480 | 0.020 |
Why?
| | Edema | 1 | 2011 | 128 | 0.020 |
Why?
| | Polyethylene | 1 | 2010 | 15 | 0.020 |
Why?
| | Body Height | 1 | 1991 | 205 | 0.020 |
Why?
| | Gastroscopes | 1 | 2010 | 3 | 0.020 |
Why?
| | Esophageal pH Monitoring | 1 | 2010 | 22 | 0.020 |
Why?
| | Epithelium | 1 | 2011 | 311 | 0.020 |
Why?
| | Palliative Care | 1 | 2019 | 1032 | 0.020 |
Why?
| | Duodenoscopy | 1 | 2009 | 8 | 0.020 |
Why?
| | Methods | 1 | 1989 | 68 | 0.020 |
Why?
| | Preoperative Care | 1 | 1992 | 381 | 0.020 |
Why?
| | Punctures | 1 | 1989 | 41 | 0.020 |
Why?
| | Diet | 1 | 2017 | 1284 | 0.020 |
Why?
| | Radiography | 1 | 1992 | 862 | 0.020 |
Why?
| | Hydrogen-Ion Concentration | 2 | 2001 | 536 | 0.020 |
Why?
| | Reference Values | 1 | 1991 | 800 | 0.020 |
Why?
| | Injections | 1 | 2010 | 200 | 0.020 |
Why?
| | Psychiatric Status Rating Scales | 1 | 1991 | 537 | 0.020 |
Why?
| | Adenocarcinoma, Papillary | 1 | 2009 | 11 | 0.020 |
Why?
| | Proto-Oncogene Proteins c-kit | 1 | 2009 | 74 | 0.020 |
Why?
| | Kaplan-Meier Estimate | 1 | 2011 | 975 | 0.020 |
Why?
| | Light | 1 | 2011 | 403 | 0.020 |
Why?
| | Age Distribution | 1 | 2009 | 406 | 0.020 |
Why?
| | Sex Distribution | 1 | 2009 | 390 | 0.020 |
Why?
| | Nervous System Diseases | 1 | 1991 | 288 | 0.020 |
Why?
| | Muscle Contraction | 1 | 1991 | 429 | 0.020 |
Why?
| | ras Proteins | 1 | 2009 | 153 | 0.020 |
Why?
| | Radiopharmaceuticals | 1 | 2008 | 210 | 0.020 |
Why?
| | Fluorodeoxyglucose F18 | 1 | 2008 | 165 | 0.020 |
Why?
| | Proto-Oncogene Proteins p21(ras) | 1 | 2009 | 256 | 0.020 |
Why?
| | Age Factors | 1 | 2015 | 3372 | 0.020 |
Why?
| | Specimen Handling | 1 | 2009 | 183 | 0.020 |
Why?
| | Intraoperative Complications | 1 | 2008 | 158 | 0.020 |
Why?
| | Decision Making | 1 | 2014 | 994 | 0.020 |
Why?
| | Early Diagnosis | 1 | 2008 | 254 | 0.020 |
Why?
| | Cell Transformation, Neoplastic | 1 | 2009 | 340 | 0.020 |
Why?
| | Safety Management | 1 | 2007 | 128 | 0.010 |
Why?
| | Thoracic Surgery | 1 | 2008 | 143 | 0.010 |
Why?
| | Survival Analysis | 1 | 2009 | 1386 | 0.010 |
Why?
| | Analysis of Variance | 1 | 2008 | 1302 | 0.010 |
Why?
| | Proto-Oncogene Proteins | 1 | 2009 | 627 | 0.010 |
Why?
| | Exercise | 1 | 2017 | 2219 | 0.010 |
Why?
| | Immunohistochemistry | 1 | 2009 | 1730 | 0.010 |
Why?
| | Cross-Sectional Studies | 2 | 2008 | 6011 | 0.010 |
Why?
| | Comorbidity | 1 | 2009 | 1672 | 0.010 |
Why?
| | Personnel Staffing and Scheduling | 1 | 2004 | 99 | 0.010 |
Why?
| | Child | 2 | 2018 | 22979 | 0.010 |
Why?
| | Infant | 1 | 2018 | 10194 | 0.010 |
Why?
| | Sex Factors | 1 | 2009 | 2136 | 0.010 |
Why?
| | False Negative Reactions | 1 | 2002 | 61 | 0.010 |
Why?
| | Gastric Acidity Determination | 1 | 2002 | 6 | 0.010 |
Why?
| | Reoperation | 2 | 1996 | 644 | 0.010 |
Why?
| | Energy Transfer | 1 | 2001 | 48 | 0.010 |
Why?
| | Attitude of Health Personnel | 1 | 2009 | 1220 | 0.010 |
Why?
| | Computer Simulation | 1 | 2004 | 1018 | 0.010 |
Why?
| | Cholangiocarcinoma | 1 | 2001 | 110 | 0.010 |
Why?
| | Equipment Failure | 1 | 1998 | 115 | 0.010 |
Why?
| | Safety | 1 | 1998 | 358 | 0.010 |
Why?
| | Radiology, Interventional | 1 | 1996 | 49 | 0.010 |
Why?
| | Blood Pressure Determination | 1 | 1995 | 145 | 0.010 |
Why?
| | Oximetry | 1 | 1995 | 125 | 0.010 |
Why?
| | Technetium Tc 99m Disofenin | 1 | 1992 | 3 | 0.010 |
Why?
| | Sincalide | 1 | 1992 | 5 | 0.010 |
Why?
| | Organotechnetium Compounds | 1 | 1992 | 12 | 0.010 |
Why?
| | Imino Acids | 1 | 1992 | 6 | 0.010 |
Why?
| | Gallbladder | 1 | 1992 | 15 | 0.010 |
Why?
| | Electrocardiography | 1 | 1995 | 675 | 0.010 |
Why?
| | Radionuclide Imaging | 1 | 1992 | 116 | 0.010 |
Why?
| | Aniline Compounds | 1 | 1992 | 120 | 0.010 |
Why?
| | Glycine | 1 | 1992 | 186 | 0.010 |
Why?
| | Chronic Disease | 1 | 1995 | 1844 | 0.000 |
Why?
| | Pregnancy | 1 | 2001 | 7274 | 0.000 |
Why?
|
|
Edmundowicz's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|